Institutional Ownership Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL). We have compiled data on the 149 institutions that hold shares in the stock, with a total of 115 Million shares, which have been reported (via 13F filing form) to have a value of $485 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
27,525,640
shares
|
$118 Million
0.96% of portfolio
|
Q1 2024
Added 20.15%
|
|
|
Capital World Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
13,361,096
shares
|
$57.2 Million
0.01% of portfolio
|
Q1 2025
Added 68.41%
|
|
|
Baillie Gifford & CO
|
Aug 06, 2025 Q2 2025 |
10,360,004
shares
|
$44.3 Million
0.03% of portfolio
|
Q2 2025
Reduced 7.47%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
8,471,619
shares
|
$36.3 Million
0.01% of portfolio
|
Q2 2025
Reduced 45.94%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
4,547,315
shares
|
$19.5 Million
0.02% of portfolio
|
Q1 2024
Reduced 0.68%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
4,110,852
shares
|
$17.6 Million
0.03% of portfolio
|
Q2 2025
Added 31.47%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Aug 14, 2025 Q2 2025 |
4,105,095
shares
|
$17.6 Million
0.29% of portfolio
|
Q2 2023
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
4,070,300
shares
|
$17.4 Million
0.03% of portfolio
|
Q2 2025
Added 53.9%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,803,477
shares
|
$16.3 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.49%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
3,447,925
shares
|
$14.8 Million
0.0% of portfolio
|
Q2 2025
Reduced 32.16%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
3,397,589
shares
|
$14.5 Million
0.01% of portfolio
|
Q2 2025
Added 290.66%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
3,344,568
shares
|
$14.3 Million
0.41% of portfolio
|
Q2 2025
Reduced 20.0%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
3,307,429
shares
|
$14.2 Million
0.02% of portfolio
|
Q2 2025
Added 14.28%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
2,889,760
shares
|
$12.4 Million
0.0% of portfolio
|
Q2 2025
Added 59.26%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
2,600,000
shares
|
$11.1 Million
0.53% of portfolio
|
Q1 2025
Added 0.67%
|
|
|
Guardian Capital Advisors LP
Toronto, A6 |
Nov 12, 2024 Q3 2024 |
1,786,414
shares
|
$7.65 Million
0.48% of portfolio
|
Q4 2022
Reduced 52.19%
|
|
|
Guardian Partners Inc.
Toronto, Z4 |
Aug 07, 2025 Q2 2025 |
1,786,414
shares
|
$7.65 Million
0.68% of portfolio
|
Q4 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
996,927
shares
|
$4.27 Million
0.0% of portfolio
|
Q2 2025
Reduced 22.78%
|
|
|
Novo Holdings
Hellerup, G7 |
Aug 14, 2025 Q2 2025 |
652,529
shares
|
$2.79 Million
0.2% of portfolio
|
Q2 2025
Reduced 42.1%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
630,938
shares
|
$2.7 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
614,293
shares
|
$2.63 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.05%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
594,288
shares
|
$2.54 Million
0.0% of portfolio
|
Q2 2025
Added 139.01%
|
|
|
Intellectus Partners, LLC
San Francisco, CA |
Aug 05, 2025 Q2 2025 |
548,133
shares
|
$2.35 Million
0.42% of portfolio
|
Q1 2025
Added 0.11%
|
|
|
Lazard Asset Management LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
509,794
shares
|
$2.18 Million
0.0% of portfolio
|
Q2 2025
Reduced 38.81%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
499,922
shares
|
$2.14 Million
0.02% of portfolio
|
Q2 2025
New holding
|